Neurovive (NEVPF) 0.6000 $NEVPF Neurovive

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Neurovive (NEVPF) 0.6000 $NEVPF

Neurovive Pharmaceutical: NeuroVive's novel strategy for treatment of mitochondrial disease published in Nature Communications
BusinessWire - Tue Aug 09, 4:11AM CDT
Regulatory News:

NeuroVive Pharmaceutical: NeuroVive Share Upgraded to OTC Markets Group - OTCQX Best Market in the US
BusinessWire - Thu Jun 02, 6:15AM CDT
Regulatory News:

Neurovive Pharmaceutical: NeuroVive's R&D Team to Present Research Progress at Mitochondrial Medicine Conference
BusinessWire - Thu Apr 28, 2:14AM CDT
NeuroVive Pharmaceutical AB (STO:NVP) (publ), the pioneers in mitochondrial medicine, will present important research findings together with researchers at Lund University in three scientific poster presentations at the conference entitled "Mitochondrial Medicine: Developing New Treatments for Mitochondrial Disease" being held 4-6 May 2016 in Cambridge, United Kingdom.

NeuroVive Pharmaceutical: NeuroVive Starts Preclinical TBI Program in Collaboration with PENN
BusinessWire - Tue Apr 26, 8:38AM CDT
Regulatory News:

NeuroVive Pharmaceutical: NeuroVive Strengthens Its Organization with the Recruitment of Cecilia Hofvander as IR and Communications Director
BusinessWire - Mon Apr 11, 1:42AM CDT
Regulatory News:

Neurovive Pharmaceutical: NeuroVive announces the CiPRICS study enrols 100 patients and reports favourable safety evaluation
BusinessWire - Mon Mar 14, 2:42AM CDT
Regulatory News:

NeuroVive Announces Departure of CEO and Appointment of Jan Nilsson as Interim CEO
BusinessWire - Tue Sep 01, 7:06AM CDT
Regulatory News:

Neurovive Pharmaceutical: NeuroVive Share Upgraded on OTC Market in US
BusinessWire - Fri Jun 26, 10:28AM CDT
Regulatory News:

Neurovive Pharmaceutical: Neurovive Reports Topline Results of Phase III CIRCUS Study in Acute Myocardial Infarction
BusinessWire - Mon Jun 01, 1:47AM CDT
Regulatory News:

NeuroVive Asia Signs Collaboration Agreement with Sanofi for the Development and Commercialization of Ciclomulsion(R) in South Korea
BusinessWire - Tue May 26, 3:30AM CDT
Regulatory News:

Neurovive Pharmaceutical: Topline Result of Phase III Study of Ciclomulsion(R) in Acute Myocardial Infarction Expected This Quarter
BusinessWire - Mon May 25, 1:43AM CDT
Regulatory News:

Neurovive Pharmaceutical: NeuroVive: Interim report 1 Jan. 2015 till 31 Mar. 2015
BusinessWire - Wed May 20, 1:54AM CDT
Regulatory News:

Global Ischemic Stroke Pipeline Report 2015
M2 - Thu May 14, 5:26AM CDT
Research and Markets (http://www.researchandmarkets.com/research/w6cj3m/ischemic_stroke) has announced the addition of the "Ischemic Stroke - Pipeline Review, H1 2015" report to their offering. This report provides comprehensive information on the therapeutic development for Ischemic Stroke, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Ischemic Stroke and special features on late-stage and discontinued projects. The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products. Companies Involved in Therapeutics Development - AB Science - Acorda Therapeutics, Inc. - Acticor Biotech - advanceCor GmbH - AGY Therapeutics, Inc. - Angion Biomedica Corp. - AstraZeneca PLC - Athersys, Inc. - Biogen Idec Inc. - BioTime, Inc. - D-Pharm Ltd. - Daiichi Sankyo Company, Limited - DiaMedica Inc. - Digna Biotech, S.L. - Genervon Biopharmaceuticals, LLC - GlaxoSmithKline plc - International Stem Cell Corporation - Laboratoires Pierre Fabre SA - Lumosa Therapeutics Co., Ltd. - MediaPharma s.r.l. - Mesoblast Limited - Mitsubishi Tanabe Pharma Corporation - Neuralstem, Inc. - Neurotec Pharma SL - NeuroVive Pharmaceutical AB - Panacea Pharmaceuticals, Inc. - Pharmicell Co., Ltd. - PhytoHealth Corporation - SanBio, Inc. - Saneron CCEL Therapeutics, Inc. - Simcere Pharmaceutical Group - Stemedica Cell Technologies, Inc. - Vicore Pharma AB - Virogenomics, Inc. For more information visit http://www.researchandmarkets.com/research/w6...mic_stroke
BIIB: 313.94 (-0.55), ACOR: 24.22 (+0.20), GSK: 44.17 (-0.22), AZN: 33.54 (-0.27), ATHX: 1.95 (-0.01), CUR: 0.20 (-0.02)

NeuroVive Pharmaceutical: NeuroVive Completes Share Issue Raising SEK 70 Million for the Preparation of CicloMulsion(R)'s Clinical Trial in the US and Commercialization in Europe
BusinessWire - Fri May 08, 1:33AM CDT
Regulatory News:

NeuroVive Announces the Intention to Raise Additional Capital Through a Private Placement
BusinessWire - Thu May 07, 10:50AM CDT
Regulatory News:

Neurovive Pharmaceutical: Clinical Phase II Study with NeuroSTAT(R) for Traumatic Brain Injury Passes Safety Evaluation
BusinessWire - Tue Apr 21, 3:06AM CDT
Regulatory News:

Neurovive Pharmaceutical: NeuroVive establishes subsidiary in Lyon and extends collaboration with HCL
BusinessWire - Mon Apr 20, 1:41AM CDT
Regulatory News:

NeuroVive Pharmaceutical: Development of NVP014 for the Treatment of Stroke Enters New Phase in Collaboration with Isomerase Therapeutics
BusinessWire - Fri Apr 17, 1:40AM CDT
Regulatory News:

NeuroVive Pharmaceutical reports change in number of shares and votes
M2 - Wed Apr 01, 3:06AM CDT
NeuroVive Pharmaceutical AB (STO:NVP), a mitochondrial medicine company, announced on Tuesday that the number of shares and votes of the company, registered with the Swedish Companies Registration Office, has increased by 1,300,000.

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Ajman Memory Gives Heritage a Durable Digital Backbone

Updated Category News Views 210

Archives usually get applause only after somebody realizes a piece of history has vanished. Ajman is trying to skip that miserable part. During the Ajman Media Forum 2026, held November 18 and 19 at the Emirates Hospitality Centre, the emirate launched Ajman Memory, a project built to collect, document and preserve photographs, papers and video recording its development....

Continue Reading
Mission Inn’s Lights Enter a Tender New Ownership Era

Updated Category News Views 412

A holiday spectacle can outlive the hands that hung its first bulb. Riverside is about to test that truth in public, under millions of tiny lights and the very large shadow of a family departure. The Mission Inn Festival of Lights returns in 2026 without Kelly and Duane Roberts as hotel owners for the first time in more than three decades. Duane Roberts died in 2025, the...

Continue Reading
Human Frontier Mission Puts AI Research on Display

Updated Category News Views 256

A laboratory notebook is about to become the real product in this AI experiment. Human Frontier Mission, or HFM, says it will launch globally on Nov. 24, opening a research program where domain specialists frame scientific and engineering problems while autonomous AI agents develop and test possible answers. The unusual bit is not merely handing models difficult work. It...

Continue Reading
Sitting, Lymph Flow, and a Supplement Maker's Pitch

Updated Category News Views 213

By late afternoon, a chair can feel like it has quietly won the argument against your legs. PureHealth Research is leaning into that familiar heavy, puffy-legged feeling with a reminder about lymphatic flow—and, naturally, an eight-ingredient supplement positioned alongside it. The broad message is sensible. The sales layer needs the usual healthy squint. Movement Does...

Continue Reading
D-Wave Investors Face a December 15 Lead Plaintiff Clock

Updated Category News Views 334

August Put the Story Under a Harsh Light Two ugly August trading sessions are doing a lot of work in the case now confronting D-Wave Quantum. The company sits in a field that attracts big dreams, big headlines, and, frankly, plenty of investor imagination. But imagination does not cushion a portfolio when expectations crack. The lawsuits concern people who bought or...

Continue Reading
3TREES Tests a Bigger Asia-Pacific Growth Blueprint

Updated Category News Views 272

A bucket of paint rarely sounds strategic until it sits inside a regional supply chain. That is the useful part of 3TREES chairman and president Hong Jie's message from the Asia-Pacific Economic Cooperation CEO Summit in Shenzhen on November 17-18, 2026: coatings are not merely a commodity if the supplier can bring materials, energy savings, technical know-how and...

Continue Reading
Lymphatic Research Gains Attention Beyond Wellness Claims

Updated Category News Views 285

Ankles leave little clues after a long day: sock grooves, puffiness, that dull heaviness nobody bothers to name. PureHealth Research wants people to look past the usual salt-and-water explanation and consider the lymphatic system, the body’s comparatively unsung network for gathering fluid from tissues and returning it to the bloodstream. Fair enough. This system does...

Continue Reading
Anthropic's Leveraged ETFs Arrive After Wild Debut

Updated Category News Views 460

Nothing says a feverish new listing quite like leveraged products lining up before the opening-week confetti has settled. Anthropic priced its IPO at $83 on November 18, raised roughly $81.3 billion, then opened Nasdaq trading at $111.50 on November 19. That is an enormous gap between IPO price and first trade, and it tells investors the obvious thing: plenty of appetite...

Continue Reading
Fluence Investors Face a November 27 Litigation Clock

Updated Category News Views 301

Six calendar squares are all that separate eligible Fluence investors from the November 27, 2026 lead-plaintiff deadline. That is not much time to locate trade confirmations, calculate losses, and decide whether taking a larger role in a securities case makes sense. The lawsuit is not a verdict, and anybody pretending otherwise is selling smoke. But the underlying...

Continue Reading
Employer Ghosting Is a Quiet Talent-Cost Problem Today

Updated Category News Views 349

Silence is cheap right up until a company needs talent again. Then the unanswered email, abandoned interview loop, or vanished promise of next steps comes back with a price tag—maybe not neatly labeled in a quarterly filing, but real all the same. LiveCareer’s April 14, 2026 survey of 1,008 employed U.S. adults lands on an uncomfortable point: candidates remember...

Continue Reading

Top 5 Most Recently Viewed Articles

Primech AI Partners for HYTRON LITE Robot Deployment in Healthcare

Updated Category News Views 301

Primech AI Signs Lease Agreement for Innovative Robot Deployment Primech AI Pte. Ltd. ("Primech AI"), a proud subsidiary of Primech Holdings Limited (NASDAQ: PMEC), is thrilled to announce a pivotal lease agreement. This collaboration is with a leading provider in facility management to deploy the revolutionary HYTRON LITE autonomous bathroom cleaning robot at a prominent...

Continue Reading
Advancements in GABAB Program: Addex and Indivior Partnership

Updated Category News Views 274

Exciting Developments in GABAB Positive Allosteric Modulators Addex Therapeutics (SIX/NASDAQ: ADXN), a leader in developing innovative small molecule allosteric modulators for neurological disorders, has announced a significant advancement with its partner Indivior. Together, they have successfully moved the GABAB positive allosteric modulator (PAM) program through the...

Continue Reading
Diligent Unveils Innovative AI Toolkits for EU Compliance

Updated Category News Views 223

Diligent Unveils AI Toolkits to Help Meet EU AI Regulations LONDON--Diligent, a key player in governance, risk, and compliance software (GRC SaaS), has rolled out its new Artificial Intelligence (AI) Act Toolkits. These valuable resources are tailored for corporate secretaries, compliance teams, chief technology officers, and audit teams, helping them navigate the complex...

Continue Reading
Examining Oracle's Competitive Standings in Software Industry

Updated Category News Views 206

Understanding Oracle's Competitive Landscape In today's dynamic and competitive market, it's crucial for investors and enthusiasts to conduct a thorough analysis of companies. This article will explore a detailed comparison, particularly focusing on Oracle (NYSE: ORCL) and its major peers in the software sector. By reviewing various financial metrics, market positioning,...

Continue Reading
Enthusiast Gaming's Response to Postal Disruption for Meeting Materials

Updated Category News Views 122

Enthusiast Gaming Addresses Postal Strike Impact Enthusiast Gaming Holdings Inc. (TSX: EGLX) is a well-known digital publisher dedicated to creating enriching experiences for gamers. With the ongoing Canada Post strike creating potential disruptions, the Company is proactively addressing how it may affect shareholder communications, specifically regarding the meeting...

Continue Reading